Analysts expect LENZ Therapeutics, Inc. to report revenue of 4.25 M for Q3 26, against a range of 3.86 M to 4.65 M. The most recent reported quarter, Q2 26, came in at 5.49 M, a 116.9% beat against the 2.53 M consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 5.00 M | 12.50 M | 1.59 M | 1.90 M | 5.49 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 797,321.96 | 4.65 M | 3.20 M | 1.89 M | 2.72 M | 4.65 M | 5.39 M | 5.88 M | 7.98 M | 10.06 M | 9.30 M | 20.74 M | 23.38 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 674,172.58 | 4.14 M | 2.71 M | 1.76 M | 2.34 M | 3.86 M | 4.53 M | 5.08 M | 7.14 M | 8.34 M | 8.61 M | 17.92 M | 21.40 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 735,747.27 | 4.40 M | 2.95 M | 1.82 M | 2.53 M | 4.25 M | 4.96 M | 5.48 M | 7.56 M | 9.20 M | 8.96 M | 19.33 M | 22.39 M |
Analysts expect LENZ Therapeutics, Inc. to report earnings per share of -0.97 for Q3 26, against a range of -1.00 to -0.94. The most recent reported quarter, Q2 26, came in at -1.02, a 1.0% miss against the -1.01 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.38 | -0.46 | -0.53 | -0.53 | -0.59 | -1.16 | -1.32 | -1.02 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.39 | -0.40 | -0.45 | -0.59 | -0.66 | -0.87 | -0.93 | -0.91 | -0.94 | -0.74 | -1.02 | -0.89 | -0.72 | -0.71 | -0.46 | -0.24 | ||||||||||
| Low Estimate | -0.47 | -0.48 | -0.55 | -0.69 | -0.80 | -1.03 | -1.11 | -1.11 | -1.00 | -0.84 | -1.22 | -0.95 | -0.82 | -0.83 | -0.52 | -0.26 | ||||||||||
| Consensus Estimate | -0.43 | -0.44 | -0.50 | -0.64 | -0.73 | -0.95 | -1.02 | -1.01 | -0.97 | -0.79 | -1.12 | -0.92 | -0.77 | -0.77 | -0.49 | -0.25 |
Pull Wall Street consensus for LENZ Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LENZ&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LENZ", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LENZ&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();